Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Zhang, Lingmin ^a   Wang, Ning ^a   Zhou, Suna ^b   Ye, Wenguang ^b   Yao, Qinglin ^b   Jing, Guixia ^a   Zhang, Mingxin ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Esophagectomy; Immunosuppression; Postoperative complications; Recurrence; Ulinastatin

Indexed keywords

ANALGESIC AGENT; CISPLATIN; ELASTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; ULINASTATIN;

ANASTOMOSIS LEAKAGE; ANASTOMOSIS STENOSIS; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ATELECTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG EDEMA; MALE; PNEUMONIA; POSTOPERATIVE COMPLICATION; RECURRENCE FREE SURVIVAL; SURGICAL INFECTION;

ADENOCARCINOMA; ADULT; AGED; CARBON DIOXIDE; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OXYGEN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RESPIRATORY MECHANICS; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS; TRYPSIN INHIBITORS; YOUNG ADULT;

EID: 84875950192     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-84     Document Type: Article

References (29)

1. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001, 233:338-344. 10.1097/00000658-200103000-00006, 1421248, 11224620.
2. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, Akiyama Y, Ishida K, Saito K, Endo S. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002, 236:184-190. 10.1097/00000658-200208000-00006, 1422564, 12170023.
3. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Abraham E, Kitajima M, Ishizaka A. Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery?. Dis Esophagus 2006, 19:5-9. 10.1111/j.1442-2050.2006.00529.x, 16364036.
4. Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M, Matsuura K, Nagamine I, Ikeda T, Ohara M, Hamai Y. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. Oncol Rep 2006, 15:895-901.
5. Khansari DN, Murgo AJ, Faith RE. Effects of stress on the immune system. Immunol Today 1990, 11:170-175.
6. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, Naritake Y, Hosokawa T, Kajiwara T. Suppression of cellular immunity by surgical stress. Surgery 2000, 127:329-336. 10.1067/msy.2000.103498, 10715990.
7. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 2003, 10:972-992. 10.1245/ASO.2003.02.007, 14527919.
8. Masuda T, Sato K, Noda C, Ikeda KM, Matsunaga A, Ogura MN, Shimizu K, Nagasawa H, Matsuyama N, Izumi T. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 2003, 31:1987-1992. 10.1097/01.CCM.0000057037.44171.BA, 12847393.
9. Inoue K, Takano H, Yanagisawa R, Yoshikawa T. Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide. J Clin Biochem Nutr 2008, 43:139-142. 10.3164/jcbn.2008059, 2581759, 19015747.
10. Uemura K, Murakami Y, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. J Surg Oncol 2008, 98:309-313. 10.1002/jso.21098, 18548482.
11. Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg 1999, 177:78-82. 10.1016/S0002-9610(98)00300-6, 10037314.
12. Bao P, Gao W, Li S, Zhang L, Qu S, Wu C, Qi H. Effect of pretreatment with high-dose ulinastatin in preventing radiation-induced pulmonary injury in rats. Eur J Pharmacol 2009, 603:114-119. 10.1016/j.ejphar.2008.12.007, 19101537.
13. Sato N, Endo S, Kimura Y, Ikeda K, Aoki K, Iwaya T, Akiyama Y, Noda Y, Saito K. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg 2002, 19:300-305. 10.1159/000064578, 12207074.
14. D'Journo XB, Michelet P, Marin V, Diesnis I, Blayac D, Doddoli C, Bongrand P, Thomas PA. An early inflammatory response to oesophagectomy predicts the occurrence of pulmonary complications. Eur J Cardiothorac Surg 2010, 37:1144-1151. 10.1016/j.ejcts.2009.11.033, 20034808.
15. Lin E, Lowry SF. Inflammatory cytokines in major surgery: a functional perspective. Intensive Care Med 1999, 25:255-257. 10.1007/s001340050832, 10229158.
16. Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002, 123:661-669. 10.1067/mtc.2002.120350, 11986593.
17. Lagarde SM, de Boer JD, ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg 2008, 247:71-76. 10.1097/SLA.0b013e31815b695e, 18156925.
18. Takagi K, Yamamori H, Morishima Y, Toyoda Y, Nakajima N, Tashiro T. Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy. Nutrition 2001, 17:13-17. 10.1016/S0899-9007(00)00504-9, 11165881.
19. Park JH, Kwak SH, Jeong CW, Bae HB, Kim SJ. Effect of ulinastatin on cytokine reaction during gastrectomy. Korean J Anesthesiol 2010, 58:334-337. 10.4097/kjae.2010.58.4.334, 2876852, 20508788.
20. Sato A, Kuwabara Y, Shinoda N, Kimura M, Ishiguro H, Fujii Y. Use of low dose dopamine, gabexate mesilate and ulinastatin reduces the water balance and pulmonary complication in thoracic esophagectomy patients. Dis Esophagus 2005, 18:151-154. 10.1111/j.1442-2050.2005.00485.x, 16045575.
21. Kobayashi H, Suzuki M, Tanaka Y, Hirashima Y, Terao T. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem 2001, 276:2015-2022. 10.1074/jbc.M007650200, 11050091.
22. Zhao X, Sun X, Gao F, Luo J, Sun Z. Effects of ulinastatin and docetaxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α. J Exp Clin Cancer Res 2011, 30:22. 10.1186/1756-9966-30-22, 3050767, 21345194.
23. Uchida K, Kusuda T, Koyabu M, Miyoshi H, Fukata N, Sumimoto K, Fukui Y, Sakaguchi Y, Ikeura T, Shimatani M. Regulatory T cells in type 1 autoimmune pancreatitis. Int J Rheumatol 2012, 2012:795026. 3321297, 22536257.
24. Yu WK, Li WQ, Li N, Li JS. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology 2004, 4:233-243. 10.1159/000078748, 15166475.
25. Chen L, Linsley PS, Hellström KE. Costimulation of T cells for tumor immunity. Immunol Today 1993, 14:483-486. 10.1016/0167-5699(93)90262-J, 7506034.
26. Nozoe T, Maehara Y, Sugimachi K. Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: its prognostic significance. World J Gastroenterol 2005, 11:6689-6693.
27. Guo SJ, Lin DM, Li J, Liu RZ, Zhou CX, Wang DM, Ma WB, Zhang YH, Zhang SR. Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 2007, 20:107-116. 10.1111/j.1442-2050.2007.00655.x, 17439593.
28. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 1999, 86:1537-1543. 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D, 10526283.
29. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550. 10.1038/nrc1388, 15229479.